Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912282-13-000064
Filing Date
2013-02-04
Accepted
2013-02-04 16:39:26
Documents
1
Group Members
MM ASSET MANAGEMENT INC.

Document Format Files

Seq Description Document Type Size
1 mmcap13g-somaxon_020413.htm SC 13G 94440
  Complete submission text file 0000912282-13-000064.txt   96092
Mailing Address P.O. BOX 32021, SMB ADMIRAL FINANCIAL CENTRE, 90 FORT STREET GRAND CAYMAN E9 BWI
Business Address P.O. BOX 32021, SMB ADMIRAL FINANCIAL CENTRE, 90 FORT STREET GRAND CAYMAN E9 BWI 416-408-0997
MMCAP International Inc. SPC (Filed by) CIK: 0001304857 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130
Business Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Subject) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81290 | Film No.: 13570529
SIC: 2834 Pharmaceutical Preparations